Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.
Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study.
复制标题
DOI:
10.3109/14767058.2013.806905
复制
发表时间:
2014-01
期刊:
影响因子:
--
通讯作者:
Hassan SS
中科院分区:
文献类型:
--
作者:
Chaiworapongsa T;Romero R;Korzeniewski SJ;Cortez JM;Pappas A;Tarca AL;Chaemsaithong P;Dong Z;Yeo L;Hassan SS
To prospectively determine the prognostic value of maternal plasma concentrations of placental growth factor (PlGF), soluble endoglin (sEng) and soluble vascular endothelial growth factor receptors-1 and −2 (sVEGFR-1 and −2) in identifying patients with suspected preeclampsia (PE) who require preterm delivery (PTD) or develop adverse outcomes. This prospective cohort study included 85 consecutive patients who presented to the obstetrical triage area at 20–36 weeks with a diagnosis of ‘rule out PE’. Patients were classified as: 1) those who remained stable until term (n=37); and 2) those who developed severe PE and required PTD (n=48). Plasma concentrations of PlGF, sEng and sVEGFR-1 and −2 were determined by ELISA. Patients with PlGF/sVEGFR-1 ≤0.05 multiples of the median (MoM) or PlGF/sEng ≤0.07 MoM were more likely to deliver preterm due to PE [adjusted odd ratio (aOR) 7.4 and 8.8], and to develop maternal (aOR 3.7 and 2.4) or neonatal complications (aOR 10.0 and 10.1). Among patients who presented <34 weeks of gestation, PlGF/sVEGFR-1 ≤ 0.035 MoM or PlGF/sEng ≤0.05 MoM had a sensitivity of 89% (16/18), specificity of 96% (24/25) and likelihood ratio for a positive test of 22 to identify patients who delivered within two weeks. The addition of the PlGF/sVEGFR-1 ratio to standard clinical tests improved the sensitivity at a fixed false-positive rate of 3% (p=0.004) for the identification of patients who were delivered due to PE within two weeks. Among patients who had a plasma concentration of PlGF/sVEGFR-1 ratio ≤ 0.035 MoM, 0.036–0.34 MoM and ≥ 0.35 MoM, the rates of PTD < 34 weeks were 94%, 27% and 7%, respectively. The determination of angiogenic/anti-angiogenic factors has prognostic value in patients presenting to the obstetrical triage area with suspected preeclampsia for the identification of those requiring preterm delivery and at risk for adverse maternal/neonatal outcomes.
登录
查看更多内容
DOI:
10.1016/0002-9378(89)90096-3
发表时间:
1989-01-01
影响因子:
9.8
作者:
DEBOER, K;TENCATE, JW;TREFFERS, PE
通讯作者:
TREFFERS, PE
DOI:
10.1016/j.ejogrb.2011.07.025
发表时间:
2011-11-01
影响因子:
2.6
作者:
Ananth, Cande V.;Vintzileos, Anthony M.
通讯作者:
Vintzileos, Anthony M.
DOI:
10.3109/14767058.2011.589932
发表时间:
2011-10-01
影响因子:
1.8
作者:
Chaiworapongsa, Tinnakorn;Romero, Roberto;Hassan, Sonia S.
通讯作者:
Hassan, Sonia S.
影响因子:
37.8
作者:
Cook, Nancy R.
通讯作者:
Cook, Nancy R.
影响因子:
9.8
作者:
Chaiworapongsa, T;Romero, R;Edwin, S
通讯作者:
Edwin, S